Chicago Biotech Network Welcomes New City and State Resources for Biotech

Jun 16, 2000, 01:00 ET from Chicago Biotech Network

    CHICAGO, June 16 /PRNewswire/ -- The Chicago Biotech Network (CBN) will
 host a panel of key officials from the City of Chicago and the State of
 Illinois describing new resources available to assist local biotech companies
 at a CBN Biotech Business Seminar, Tuesday, June 20, 2000, from 5:00 PM to
 8:00 PM, at the University of Illinois at Chicago, Molecular Biology Research
 Building, 900 South Ashland Avenue, Chicago.
     Recently, both the City of Chicago and the State of Illinois launched new
 support for biotech entrepreneurs, including expanded technology research
 grants, technology centers, and a seed capital fund dedicated to biotech.
     Guest speakers for June 20th are: Shaye R. Mandle, President of The
 Illinois Coalition; Lori J. Clark, Deputy Director, Bureau of Technology and
 Industrial Competitiveness for the Illinois Department of Commerce &
 Community Affairs; James Downing, Program Administrator for the Illinois
 Development Finance Authority; Katherine Gehl, Assistant to the Mayor for
 Technology Development, Office Of Mayor, City of Chicago; and, E. Daniel
 Lyne, Director of Technology Business Development for the Chicago Partnership
 for Economic Development.
     Moderator will be CBN Director, Michael D. Becker, an Investment
 Executive/Analyst with Wayne Hummer Investments LLC in Chicago, and Editor of
 the highly respected  "Beck on Biotech" Newsletter ( www.beckonbiotech.com ).
     According to Mr. Becker, "Due to the expected tidal wave of new genetic
 information resulting from public and private efforts to sequence the human
 genome, it is now more critical than ever to ensure that companies in this
 emerging industry have sufficient support from state and local government to
 help bring new therapeutics and diagnostics to the market.  While Illinois is
 home to several leading pharmaceutical companies and academic institutions,
 dedicated funds and other financial incentives are needed to establish the
 state as a serious participant in the biotechnology sector."
     The Chicago Biotech Network (CBN) is an industry-led, not-for-profit trade
 association with over 150 corporate members ranging from biotech start-ups to
 multinational pharmaceutical corporations and venture capital firms. CBN is
 dedicated to helping local biotech companies grow and to promoting the
 biotechnology industry in Chicago and across Illinois. For more information,
 contact CBN President, Marci Buettgen:  Phone: 312-CBN-0123, or, E-mail:
 mdbchgo@aol.com .
     The June 20th CBN Biotech Business Seminar is offered free of charge, but
 pre-registration is required.  To register, contact the Chicago Biotech
 Network by phone: 312-CBN-0123, or e-mail: mdbchgo@aol.com .
 
 

SOURCE Chicago Biotech Network
    CHICAGO, June 16 /PRNewswire/ -- The Chicago Biotech Network (CBN) will
 host a panel of key officials from the City of Chicago and the State of
 Illinois describing new resources available to assist local biotech companies
 at a CBN Biotech Business Seminar, Tuesday, June 20, 2000, from 5:00 PM to
 8:00 PM, at the University of Illinois at Chicago, Molecular Biology Research
 Building, 900 South Ashland Avenue, Chicago.
     Recently, both the City of Chicago and the State of Illinois launched new
 support for biotech entrepreneurs, including expanded technology research
 grants, technology centers, and a seed capital fund dedicated to biotech.
     Guest speakers for June 20th are: Shaye R. Mandle, President of The
 Illinois Coalition; Lori J. Clark, Deputy Director, Bureau of Technology and
 Industrial Competitiveness for the Illinois Department of Commerce &
 Community Affairs; James Downing, Program Administrator for the Illinois
 Development Finance Authority; Katherine Gehl, Assistant to the Mayor for
 Technology Development, Office Of Mayor, City of Chicago; and, E. Daniel
 Lyne, Director of Technology Business Development for the Chicago Partnership
 for Economic Development.
     Moderator will be CBN Director, Michael D. Becker, an Investment
 Executive/Analyst with Wayne Hummer Investments LLC in Chicago, and Editor of
 the highly respected  "Beck on Biotech" Newsletter ( www.beckonbiotech.com ).
     According to Mr. Becker, "Due to the expected tidal wave of new genetic
 information resulting from public and private efforts to sequence the human
 genome, it is now more critical than ever to ensure that companies in this
 emerging industry have sufficient support from state and local government to
 help bring new therapeutics and diagnostics to the market.  While Illinois is
 home to several leading pharmaceutical companies and academic institutions,
 dedicated funds and other financial incentives are needed to establish the
 state as a serious participant in the biotechnology sector."
     The Chicago Biotech Network (CBN) is an industry-led, not-for-profit trade
 association with over 150 corporate members ranging from biotech start-ups to
 multinational pharmaceutical corporations and venture capital firms. CBN is
 dedicated to helping local biotech companies grow and to promoting the
 biotechnology industry in Chicago and across Illinois. For more information,
 contact CBN President, Marci Buettgen:  Phone: 312-CBN-0123, or, E-mail:
 mdbchgo@aol.com .
     The June 20th CBN Biotech Business Seminar is offered free of charge, but
 pre-registration is required.  To register, contact the Chicago Biotech
 Network by phone: 312-CBN-0123, or e-mail: mdbchgo@aol.com .
 
 SOURCE  Chicago Biotech Network